These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22452658)

  • 1. Hierarchical virtual screening: identification of potential high-affinity and selective β(3)-adrenergic receptor agonists.
    Saxena AK; Roy KK
    SAR QSAR Environ Res; 2012 Jul; 23(5-6):389-407. PubMed ID: 22452658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the binding modes of human β₃-adrenergic receptor agonists with ligand-based and receptor-based methods.
    Jin F; Lu C; Sun X; Li W; Liu G; Tang Y
    Mol Divers; 2011 Nov; 15(4):817-31. PubMed ID: 21424594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of beta3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for beta3 adrenergic receptor agonism.
    Prathipati P; Saxena AK
    J Comput Aided Mol Des; 2005 Feb; 19(2):93-110. PubMed ID: 16075304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel β3-adrenoceptor agonists using energetic analysis, structure based pharmacophores and virtual screening.
    Tewatia P; Malik BK; Sahi S
    Comb Chem High Throughput Screen; 2012 Sep; 15(8):623-40. PubMed ID: 22375887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.
    Michel MC; Cernecka H; Ochodnicky P
    Eur J Pharmacol; 2011 Apr; 657(1-3):1-3. PubMed ID: 21315709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β(3)-Adrenoceptor agonists and (antagonists as) inverse agonists history, perspective, constitutive activity, and stereospecific binding.
    Grazia Perrone M; Scilimati A
    Methods Enzymol; 2010; 484():197-230. PubMed ID: 21036234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
    Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
    J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of high affinity ligands for β2-adrenergic receptor through pharmacophore-based high-throughput virtual screening and docking.
    Yakar R; Akten ED
    J Mol Graph Model; 2014 Sep; 53():148-160. PubMed ID: 25137647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potential pancreatic cholesterol esterase inhibitors using pharmacophore modelling, virtual screening, and optimization studies.
    John S; Thangapandian S; Sakkiah S; Lee KW
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):535-45. PubMed ID: 21143043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.
    Wei J; Wang S; Gao S; Dai X; Gao Q
    J Chem Inf Model; 2007; 47(2):613-25. PubMed ID: 17330954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
    Krovat EM; Langer T
    J Med Chem; 2003 Feb; 46(5):716-26. PubMed ID: 12593652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists.
    Singh N; Nolan TL; McCurdy CR
    J Mol Graph Model; 2008 Sep; 27(2):131-9. PubMed ID: 18456526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
    Blin N; Camoin L; Maigret B; Strosberg AD
    Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
    Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
    J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the conformational perturbations of novel agonists with β3-adrenergic receptor using molecular dynamics simulations.
    Tewatia P; Agrawal N; Gaur M; Sahi S
    Biochimie; 2014 Jun; 101():168-82. PubMed ID: 24508605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.
    Hattori K; Orita M; Toda S; Imanishi M; Itou S; Nakajima Y; Tanabe D; Washizuka K; Araki T; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4679-83. PubMed ID: 19608416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of benzamides as potent human β3 adrenergic receptor agonists.
    Zhu C; Kar NF; Li B; Costa M; Dingley KH; Di Salvo J; Ha SN; Hurley AL; Li X; Miller RR; Salituro GM; Struthers M; Weber AE; Hale JJ; Edmondson SD
    Bioorg Med Chem Lett; 2016 Jan; 26(1):55-9. PubMed ID: 26590100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.